Cargando…
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers
BACKGROUND: This study aimed at monitoring the kinetics of serum total anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antibodies in a cohort of healthcare workers after voluntary vaccination with Pfizer-BioNTech coronavirus disease 2019 (COVID-19) mRNA-based vaccine. METHODS: The...
Autores principales: | Salvagno, Gian Luca, Henry, Brandon M., Pighi, Laura, de, Nitto Simone, Lippi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Medical Biochemists of Serbia, Belgrade
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010038/ https://www.ncbi.nlm.nih.gov/pubmed/35510202 http://dx.doi.org/10.5937/jomb0-33999 |
Ejemplares similares
-
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021) -
6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers
por: Cham, Jason, et al.
Publicado: (2022) -
585. Safety of Pfizer-BioNtech COVID-19 Vaccine in Healthcare Workers, Singapore
por: Kam, Kai-Qian, et al.
Publicado: (2021) -
Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers
por: Im, Jae Hyoung, et al.
Publicado: (2021) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)